文献速递细菌感染、耐药与抗菌药物

COVID-19大流行的经验如何加强抗菌药物耐药性监测与抗菌药物管理

How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?
PubMed 文献 · Lancet Infect Dis · 2023-06-05

本文探讨COVID-19大流行期间抗菌药物广泛使用对AMR管理的不利影响,总结疫情防控中集中治理、风险沟通、技术追踪、诊断可及性和全球成人疫苗接种等关键策略,提出可利用这些经验加强AMR监测与管理、重振应对AMR危机的努力。

要点

  • COVID-19大流行期间抗菌药物的广泛和无差别使用对AMR管理实践产生不利影响。
  • 控制SARS-CoV-2感染的关键策略包括集中治理与本地实施、循证风险沟通、技术追踪、诊断可及性扩大和全球成人疫苗接种。
  • 可从大流行中汲取经验以加强AMR监测与管理并重振应对AMR危机的努力。

核心结论

  • COVID-19大流行期间抗菌药物的广泛和无差别使用对AMR管理实践产生不利影响,但大流行中汲取的经验可用于加强监测与管理并重振应对AMR危机的努力。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 2019年WHO宣布AMR为人类面临的十大全球公共卫生威胁之一,抗菌药物误用和过度使用是耐药病原体发展的主要驱动因素。
  • AMR正在稳步上升,尤其在低收入和中等收入国家,包括南亚、南美和非洲。
  • COVID-19大流行凸显全球卫生系统的脆弱性,迫使政府和全球机构创造性地思考。
  • 控制SARS-CoV-2感染的关键策略包括集中治理与本地实施、循证风险沟通与社区参与、用于追踪和问责的技术方法、诊断可及性的广泛扩展以及全球成人疫苗接种规划。
  • 大流行早期用于治疗患者的抗菌药物广泛和无差别使用对AMR管理实践产生不利影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

COVID-19 demanded urgent and immediate global attention, during which other public health crises such as antimicrobial resistance (AMR) increased silently, undermining patient safety and the life-saving ability of several antimicrobials. In 2019, WHO declared AMR a top ten global public health threat facing humanity, with misuse and overuse of antimicrobials as the main drivers in the development of antimicrobial-resistant pathogens. AMR is steadily on the rise, especially in low-income and middle-income countries across south Asia, South America, and Africa. Extraordinary circumstances often demand an extraordinary response as did the COVID-19 pandemic, underscoring the fragility of health systems across the world and forcing governments and global agencies to think creatively. The key strategies that helped to contain the increasing SARS-CoV-2 infections included a focus on centralised governance with localised implementation, evidence-based risk communication and community engagement, use of technological methods for tracking and accountability, extensive expansion of access to diagnostics, and a global adult vaccination programme. The extensive and indiscriminate use of antimicrobials to treat patients, particularly in the early phase of the pandemic, have adversely affected AMR stewardship practices. However, there were important lessons learnt during the pandemic, which can be leveraged to strengthen surveillance and stewardship, and revitalise efforts to address the AMR crisis.

来源:Lancet Infect Dis,查看原文。版权归原作者所有。

引用

  1. Walia K, Mendelson M, Kang G, et al. How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship? Lancet Infect Dis. 2023. PMID: 37290476. doi:10.1016/S1473-3099(23)00124-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。